KIT and extraskeletal myxoid chondrosarcoma: This event was detected in one out of 20 EMC cases analyzed, indicating that a KIT alteration is not a recurrent event in EMC, and cannot explain the EMC sensitivity to sunitinib, although it is an actionable mutation in the individual case in which it has been identified.